FDA Authorizes Hand-Held COVID-19 Diagnostic Test

Source: FierceBiotech

In response to the coronavirus crisis, we’ve seen COVID-19 diagnostics quickly evolve from early, multistep kits to high-throughput versions to fast point-of-care tests, all in just a few weeks. Now, the FDA has granted an emergency authorization to a device that fits in the palm of your hand, according to a FierceBiotech report.

Mesa Biotech’s Accula device is designed to enable near-patient testing, available anywhere outside of the laboratory, with results in about 30 minutes. Based on the company’s previous tests for influenza and respiratory syncytial virus, the compact diagnostic is aimed at temporary coronavirus screening sites, urgent care locations and long-term nursing facilities as well as small physician-run labs.

Read the full article.

Related Content